Thanks to the #EMERALD #MDPhD program students and the European MD/PhD Association for the invitation to speak at their "Finding the Creative Spark in Biomedical Research" conference at Centre for Genomic Regulation (CRG)/PRBB (Barcelona Biomedical Research Park).

NIH Medical Scientist Partnership Program - conduct your Ph.D. dissertation research in the NIH Intramural Research Program.

https://grants.nih.gov/grants/guide/pa-files/PAR-23-109.html

#NIH #funding #mdphd

PAR-23-109: NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed)

NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: NIH Medical Scientist Partnership Program (FM1 Clinical Trial Not Allowed) PAR-23-109. NIAID

Taylor is the first undergraduate in our group to complete an undergraduate honors thesis! Following graduation in May, she is planning on taking a gap year to gain more clinical experience before applying to #MDPhD programs. Recruit her before somebody else does! #NewPI #ProudPI

Got accepted to one of my absolute top choice #MSTP (#MDPhD) programs this week and it still doesn't feel real.

I am still waiting to hear back from a handful of other schools, but wow am I excited for the next step in my training.

Another impressive #pathology works in progress, this week by year five MD PhD candidate Vanessa Ruiz, MS, re: characterizing subsets of uninfected & HIV-infected CD14+CD16+ monocytes that contribute to neuropathogenesis. Vanessa is in the lab of Dr. Joan Berman. Bravo!

#cns #HIV #AIDS #neuroAIDS #bloodbrainbarrier #neurocognitive #mdphd #science #health #womeninscience @pathology

MD-PhD position at Institut Curie co-funded by the European Comission. #opportunity #academictwitter #phd #mdphd

https://emerald-mdphd.eu/hosting-institutions/ic-1/

IC#1 - Molecular biology to refine diagnostic and therapeutic strategies in adult soft tissue sarcoma

Sarcomas consist of a group of malignant tumors of mesenchymal origin with major clinical, pathological and biological heterogeneity. Over the last decades, major advances in molecular biology and genetics have led to the dismantlement of multiples subtypes of sarcomas characterized by specific molecular alterations, including gene fusions, activating mutations and epigenetic alterations. We perform translational

Emerald